Advent Pharma Ltd. (DSE:ADVENT)

Advent Pharma Revenue

Advent Pharma had revenue of 69.28M BDT in the quarter ending March 31, 2026, a decrease of -45.65%. This brings the company's revenue in the last twelve months to 458.15M, down -4.34% year-over-year. In the fiscal year ending June 30, 2025, Advent Pharma had annual revenue of 500.49M, down -12.45%.

• Revenue (ttm): 458.15M
• Revenue Growth: -4.34%
• P/S Ratio: 2.76
• Revenue / Employee: 1.45M
• Employees: 317
• Market Cap: 1.27B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	500.49M	-71.18M	-12.45%
Jun 30, 2024	571.67M	13.62M	2.44%
Jun 30, 2023	558.05M	27.58M	5.20%
Jun 30, 2022	530.47M	26.87M	5.34%
Jun 30, 2021	503.60M	-30.43M	-5.70%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 6, 2026

Data Sources Report a data error